Jeffrey Brian McGroarty is CFO at Annovis Bio, Inc. (ANVS). They have made 1 open-market trade across 1 company since 2020, most recently 2020-02-03.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $478K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANVS | 52,669 | $53K |
Shares reported on the most recent Form 4, priced at the 2020-02-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANVS | BUY | 2020-01-31 | 2020-02-05 | $6.62 | $478K | +0.5% | -22.1% | -40.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.